| Prospective trial of treat-and-extend versus monthly dosing for neovascular age-related macular degeneration: TREX-AMD 1-year results CC Wykoff, DE Croft, DM Brown, R Wang, JF Payne, L Clark, ... Ophthalmology 122 (12), 2514-2522, 2015 | 294 | 2015 |
| The natural history of the progression of atrophy secondary to Stargardt disease (ProgStar) studies: design and baseline characteristics: ProgStar Report No. 1 RW Strauss, A Ho, B Muñoz, AV Cideciyan, JA Sahel, JS Sunness, ... Ophthalmology 123 (4), 817-828, 2016 | 148 | 2016 |
| Drusen volume as a predictor of disease progression in patients with late age-related macular degeneration in the fellow eye NS Abdelfattah, H Zhang, DS Boyer, PJ Rosenfeld, WJ Feuer, G Gregori, ... Investigative ophthalmology & visual science 57 (4), 1839-1846, 2016 | 148 | 2016 |
| Noninvasive imaging of tear film dynamics in eyes with ocular surface disease NS Abdelfattah, A Dastiridou, SVR Sadda, OL Lee Cornea 34, S48-S52, 2015 | 130 | 2015 |
| Proposal of a simple optical coherence tomography-based scoring system for progression of age-related macular degeneration J Lei, S Balasubramanian, NS Abdelfattah, MG Nittala, SVR Sadda Graefe's Archive for Clinical and Experimental Ophthalmology 255, 1551-1558, 2017 | 122 | 2017 |
| Randomized trial of treat-and-extend versus monthly dosing for neovascular age-related macular degeneration: 2-year results of the TREX-AMD study CC Wykoff, WC Ou, DM Brown, DE Croft, R Wang, JF Payne, WL Clark, ... Ophthalmology Retina 1 (4), 314-321, 2017 | 117 | 2017 |
| OCT risk factors for development of late age-related macular degeneration in the fellow eyes of patients enrolled in the HARBOR study M Nassisi, J Lei, NS Abdelfattah, A Karamat, S Balasubramanian, W Fan, ... Ophthalmology 126 (12), 1667-1674, 2019 | 113 | 2019 |
| Clinical correlates of common corneal neovascular diseases: a literature review NS Abdelfattah, M Amgad, AA Zayed, H Salem, AE Elkhanany, H Hussein, ... International journal of ophthalmology 8 (1), 182, 2015 | 91 | 2015 |
| Progression of Stargardt disease as determined by fundus autofluorescence in the retrospective progression of Stargardt disease study (ProgStar report No. 9) RW Strauss, B Muñoz, A Ho, A Jha, M Michaelides, AV Cideciyan, I Audo, ... JAMA ophthalmology 135 (11), 1232-1241, 2017 | 90 | 2017 |
| Progression of Stargardt disease as determined by fundus autofluorescence over a 12-month period: ProgStar report no. 11 RW Strauss, X Kong, A Ho, A Jha, S West, M Ip, PS Bernstein, DG Birch, ... JAMA ophthalmology 137 (10), 1134-1145, 2019 | 71 | 2019 |
| Postreceptor neuronal loss in intermediate age-related macular degeneration E Borrelli, NS Abdelfattah, A Uji, MG Nittala, DS Boyer, SVR Sadda American Journal of Ophthalmology 181, 1-11, 2017 | 70 | 2017 |
| Progression of macular atrophy in patients with neovascular age-related macular degeneration undergoing antivascular endothelial growth factor therapy NS Abdelfattah, H Zhang, DS Boyer, SVR Sadda Retina 36 (10), 1843-1850, 2016 | 68 | 2016 |
| Macular sensitivity measured with microperimetry in Stargardt disease in the progression of atrophy secondary to Stargardt disease (ProgStar) study: report no. 7 EM Schönbach, Y Wolfson, RW Strauss, MA Ibrahim, X Kong, B Muñoz, ... JAMA ophthalmology 135 (7), 696-703, 2017 | 66 | 2017 |
| Visual acuity loss and associated risk factors in the retrospective Progression of Stargardt Disease Study (ProgStar Report No. 2) X Kong, RW Strauss, M Michaelides, AV Cideciyan, JA Sahel, B Muñoz, ... Ophthalmology 123 (9), 1887-1897, 2016 | 66 | 2016 |
| Macular atrophy in neovascular age-related macular degeneration with monthly versus treat-and-extend ranibizumab: findings from the TREX-AMD trial NS Abdelfattah, M Al-Sheikh, S Pitetta, A Mousa, SVR Sadda, CC Wykoff, ... Ophthalmology 124 (2), 215-223, 2017 | 63 | 2017 |
| Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8 K Fujinami, RW Strauss, IS Audo, PS Bernstein, DG Birch, SM Bomotti, ... British Journal of Ophthalmology 103 (3), 390-397, 2019 | 54 | 2019 |
| Incidence of atrophic lesions in Stargardt disease in the progression of atrophy secondary to Stargardt disease (ProgStar) study: report no. 5 RW Strauss, B Muñoz, A Ho, A Jha, M Michaelides, S Mohand-Said, ... JAMA ophthalmology 135 (7), 687-695, 2017 | 54 | 2017 |
| Repeatability and reproducibility of quantification of superficial peri-papillary capillaries by four different optical coherence tomography angiography devices J Lei, C Pei, C Wen, NS Abdelfattah Scientific reports 8 (1), 17866, 2018 | 53 | 2018 |
| Visual acuity change over 24 months and its association with foveal phenotype and genotype in individuals with Stargardt disease: ProgStar Study Report No. 10 X Kong, K Fujinami, RW Strauss, B Munoz, SK West, AV Cideciyan, ... JAMA ophthalmology 136 (8), 920-928, 2018 | 50 | 2018 |
| Visual acuity change over 12 months in the prospective progression of atrophy secondary to Stargardt disease (ProgStar) study: ProgStar report number 6 X Kong, RW Strauss, AV Cideciyan, M Michaelides, JA Sahel, B Munoz, ... Ophthalmology 124 (11), 1640-1651, 2017 | 47 | 2017 |
Srinivas SaddaDoheny Eye InstituteVerified email at doheny.org
